New shot offers hope against aggressive liver virus

NCT ID NCT07298330

Recruiting now Disease control Sponsor: Mirum Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a new injectable drug called Brelovitug can safely control Hepatitis D infection, a serious liver disease. About 80 people with chronic Hepatitis D will receive either weekly or monthly injections for nearly two years, or start treatment after a 12-week delay. The main goal is to see if the drug reduces the amount of virus in the blood and improves liver health more than waiting for treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Locations

Acibadem City Clinic University Multiprofile Hospital for Active Treatment Tokuda
RECRUITING

Sofia, 1407, Bulgaria
Aga Khan University & Hospital
RECRUITING

Karachi, Karachi, 74800, Pakistan
Alliance Clinical, Las Vegas
RECRUITING

Las Vegas, Nevada, 89019, United States
Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases
RECRUITING

Budapest, H-1097, Hungary
Cleveland Clinic
RECRUITING

Cleveland, Ohio, 44195, United States
Denver Health Medical Center
RECRUITING

Denver, Colorado, 80204, United States
Diakori LLC
RECRUITING

Tbilisi, 0159, Georgia
E-Da Hospital
RECRUITING

Kaohsiung City, 82445, Taiwan
Erasme Hospital
RECRUITING

Brussels, Belgium
Fejer County St. Gyorgy University Teaching Hospital
RECRUITING

Székesfehérvár, H-8000, Hungary
HaEmek Medical Center
RECRUITING

Haifa, 3296043, Israel
Hospital Service LTD
RECRUITING

Kutaisi, 4608, Georgia
JSC T. Tsertsvadze Infectious Diseases, AIDS and Clinical Immunology Research Center
RECRUITING

Tbilisi, 0159, Georgia
Kaiser Permanente Medical Center
RECRUITING

Sacramento, California, 95661, United States
Kaohsiung Medical University Chung-Ho Memorial Hospital
RECRUITING

Kaohsiung City, 807377, Taiwan
LTD Academician Vakhtang Bochorishvili Clinic
RECRUITING

Tbilisi, 0160, Georgia
Limited Liability Company "Medical Center Health and Rehabilitation "100 Percent Life"
RECRUITING

Poltava, 36000, Ukraine
National Taiwan University Hospital
RECRUITING

Taipei, 100225, Taiwan
Prime Clinical Research Inc
RECRUITING

Mansfield, Texas, 76063, United States
Public Non-Profit Enterprise "Central City Hospital" of Rivne City Council
RECRUITING

Rivne, 33018, Ukraine
Quest Clinical Research
RECRUITING

San Francisco, California, 94115, United States
Research Institute of Virology of the Republic of Uzbekistan
RECRUITING

Tashkent, 100194, Uzbekistan
Soroka University Medical Center
RECRUITING

Beersheba, 8410101, Israel
University Hospital Antwerp (UZA)
RECRUITING

Edegem, Belgium
University Hospital Center Sart-Tilman
RECRUITING

Liège, Belgium
University of California, Davis
RECRUITING

Davis, California, 95616, United States
University of Utah
RECRUITING

Salt Lake City, Utah, 84132, United States

Conditions

Explore the condition pages connected to this study.

CHRONIC HEPATITIS D INFECTION